Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved survival in neuroblastoma using multimodality therapy.

E M Rosen, J R Cassady, C N Frantz

    Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Urinary oxidative stress biomarker levels and reproductive outcomes among couples undergoing fertility treatments.

    Human reproduction (Oxford, England)·2019
    Same author

    Dietitians' perspectives of the barriers and enablers to delivering patient-centred care.

    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2019
    Same author

    Current Situation of Paediatric and Adult Patients With Fragile X Syndrome: Preliminary Data From the Explain Fxs Registry.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
    Same author

    Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.

    Oncogene·2007
    Same author

    Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.

    Oncogene·2007
    Same author

    Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.

    Oncogene·2006

    This study on neuroblastoma treatment found that intensive therapy improved survival for most stages. However, older patients with stage IV neuroblastoma require novel treatment approaches for better outcomes.

    Area of Science:

    • Pediatric Oncology
    • Cancer Therapeutics

    Background:

    • Neuroblastoma is a common childhood cancer.
    • Treatment strategies have evolved over time, impacting patient outcomes.

    Purpose of the Study:

    • To evaluate the effectiveness of various treatment modalities for neuroblastoma.
    • To identify patient subgroups that benefit most from current therapies.
    • To highlight challenges in treating advanced-stage neuroblastoma.

    Main Methods:

    • Retrospective analysis of 136 neuroblastoma patients treated between 1970 and 1982.
    • Therapy selection based on patient age and disease stage.
    • Utilized surgery, radiation therapy, and chemotherapy in various combinations.

    Main Results:

    Related Experiment Videos

    • Overall disease-free survival was 60%.
    • Excellent survival rates (100%) observed in Stage I and younger Stage II patients.
    • High survival rates (85-90%) for Stage III and older Stage II patients with intensive treatment.
    • Younger Stage IV patients (under 1 year) showed 92% survival with surgery and chemotherapy.
    • Older Stage IV patients (over 1 year) had poor outcomes with only 10% survival.

    Conclusions:

    • Combination therapy and multiagent chemotherapy have improved survival for specific neuroblastoma stages.
    • Current conventional therapies remain largely ineffective for older Stage IV neuroblastoma patients.
    • Development of novel therapeutic strategies is crucial for improving outcomes in older Stage IV neuroblastoma.